The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
The Cholesterol & Lipids Base Test test contains 1 test with 7 biomarkers.
Brief Description: The Cholesterol & Lipids Base test, often referred to as a lipid panel or cholesterol panel, is a comprehensive laboratory assessment that measures several markers related to cholesterol and lipids in the bloodstream. This panel includes markers such as Total Cholesterol, HDL Cholesterol, LDL Cholesterol, LDL/HDL Ratio, Non-HDL Cholesterol, Chol/HDLC Ratio, and Triglycerides. These tests provide crucial information about an individual's cardiovascular health and risk factors.
Also Known As: Lipid Profile Test, Lipid Test, Cholesterol Profile Test, Cholesterol Panel Test, Cholesterol Test, Coronary Risk Panel Test, lipid blood test, Lipid w/Ratios Test, Cholesterol Ratio test, blood cholesterol Test
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
Timing of the Test: The Cholesterol & Lipids Base test is typically ordered as part of routine health screenings, during annual check-ups, or when specific risk factors or symptoms related to cardiovascular health are present. Fasting may be required for accurate triglyceride measurements.
Reasons for Ordering the Test:
Cardiovascular Risk Assessment: The primary reason for ordering this test is to assess an individual's risk of cardiovascular disease, including heart disease and stroke. Elevated cholesterol levels and unfavorable lipid profiles are associated with an increased risk of these conditions.
Routine Health Screening: Healthcare providers often include lipid panels in routine health screenings to identify individuals at risk of heart disease, even in the absence of symptoms.
Monitoring Cholesterol Levels: For individuals with a history of high cholesterol or those on cholesterol-lowering medications, regular lipid panel testing helps monitor cholesterol levels and assess treatment effectiveness.
Assessing Treatment Effects: The Cholesterol & Lipids Base test may be ordered to evaluate the impact of lifestyle changes or medications on cholesterol and lipid profiles.
Evaluation of Cardiovascular Symptoms: In cases where patients present with symptoms such as chest pain, shortness of breath, or palpitations, lipid panel testing may be part of the diagnostic workup to assess cardiovascular risk.
The Cholesterol & Lipids Base test assesses several key markers:
Cholesterol Total: Measures the total concentration of cholesterol in the bloodstream, including both HDL and LDL cholesterol.
HDL Cholesterol: Evaluates the levels of high-density lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol. HDL helps remove excess cholesterol from the arteries.
LDL Cholesterol: Measures low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. Elevated LDL cholesterol can contribute to plaque buildup in the arteries.
LDL/HDL Ratio: Calculated by dividing the LDL cholesterol by the HDL cholesterol, this ratio provides insights into the balance between "bad" and "good" cholesterol.
Non-HDL Cholesterol: Calculated by subtracting HDL cholesterol from total cholesterol, this marker represents the total cholesterol content minus the protective HDL fraction. It is a strong predictor of cardiovascular risk.
Chol/HDLC Ratio: This ratio is calculated by dividing the total cholesterol by the HDL cholesterol and provides additional information about cardiovascular risk.
Triglycerides: Assesses the levels of triglycerides, a type of fat in the blood. Elevated triglycerides are associated with an increased risk of heart disease.
Healthcare providers use the results of the Cholesterol & Lipids Base test to:
Assess Cardiovascular Risk: Elevated cholesterol levels, particularly LDL cholesterol and triglycerides, are associated with an increased risk of heart disease. Providers use these results to assess cardiovascular risk and make recommendations for lifestyle changes, medication, or further evaluation.
Diagnose Dyslipidemia: Dyslipidemia refers to abnormal lipid levels, which can include high LDL cholesterol, low HDL cholesterol, or high triglycerides. The test helps diagnose and classify dyslipidemia.
Guide Treatment Decisions: The results of the lipid panel guide treatment decisions for lipid disorders. Treatment may involve lifestyle modifications (diet and exercise), cholesterol-lowering medications (statins), or a combination of both.
Monitor Progress: For individuals already receiving treatment for cholesterol management, regular lipid panel testing helps healthcare providers monitor progress and adjust treatment plans as needed.
In summary, the Cholesterol & Lipids Base test is a comprehensive assessment of cholesterol and lipid levels in the bloodstream. It aids in assessing cardiovascular risk, diagnosing dyslipidemia, guiding treatment decisions, and monitoring lipid profiles to ensure optimal cardiovascular health.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.